79.5 F
New York
Sunday, June 20, 2021

Cerecor [NASDAQ: CERC] Expands Agreement with Kyowa Kirin Co

Must read

Maiar Crypto App Now Supports Bitcoin

Maiar brings an exciting opportunity for Bitcoin proponents as Elrond-powered mobile app Maiar can now store and transact with Bitcoin. Maiar is a non-custodial...

Kadant [NYSE: KAI] Announces Acquisition of Joh. Clouth

Kadant Inc. disclosed Thursday that it has decided to purchase Joh. Clouth GmbH & Co. KG and its affiliates (Clouth). The firm has...

VEON [NASDAQ: VEON] Announces Acquisition of AdTech in Russia

VEON Ltd disclosed that it has purchased a majority stake in OTM which is a technology platform for the automation and planning of...

MicroStrategy Decides to Sell $1B Stock With Plans To Buy More Bitcoin With Profit

Shares of MicroStrategy Incorporated skyrocketed 5.36% on Wednesday after the firm disclosed that it has decided to dump $1 billion worth of its...

Cerecor Inc. [NASDAQ: CERC] disclosed that its unit Aevi Genomic Medicine, LLC has inked an extended agreement with Kyowa Kirin Co. The deal has been signed between the two firms for special worldwide rights to develop, produce and market CERC-002, Kyowa Kirin’s first-in-class fully human anti-LIGHT monoclonal antibody for all signs.

As per the deal, Cerecor will get the special rights for CERC-002 in Europe, Japan, and the US. Furthermore, the deal has also provided the maintained the rights of Kyowa Kirin Co in Japan. Kyowa Kirin will obtain an up-front consideration from CERC and is also entitled to receive extra payments based on the accomplishment of governing and industrial targets, as well as sales-based royalty payments and a share of subcontracting income.

Share of Cerecor Inc. surged 6.04% at $3.1600 during the pre-market trading session of Monday. CERC disclosed the firm is delighted to extend its agreement with Kyowa Kirin. The firm has recently declared showed clinically significant results with CERC-002 in sufferers with COVID-19 ARDS.

It will also proceed to search the role of LIGHT in extra inflammatory disorders. This deal will help the firm to fulfill the unmet medical needs of the sufferers by developing sophisticated therapy.

More articles

Latest article

Thailand SEC Forbids Crypto Exchanges from Listing Meme Tokens, NFTs, and More

Thailand SEC has made a new decision that forbids crypto exchanges to list meme tokens, NFTs, and many more. The decision to ban certain...

China’s Cryptocurrency Mining Crackdown Appears to be Widening

The cryptocurrency mining crackdown of China is continuously increasing. It has been seen that government departments in the province of Yunnan are gearing up...

Accenture [NYSE: ACN] and Salesforce to Aid ISDI to Reduce its Environmental Impact

Accenture plc and Salesforce have partnered with ISDI to provide aid to the Salesforce-authorized global coaching organization. The firms will evaluate their carbon...

Iconix Brand [NASDAQ: ICON] to be Acquired by Iconix Acquisition Corp

Iconix Brand Group, Inc. disclosed that it has inked an agreement and plan of merger with Iconix Acquisition Corp. Iconix Brand Group is...

Binance Cryptocurrency Exchange to Launch a New NFT Platform

The Binance cryptocurrency exchange will be introducing a new on-chain NFT platform called "Featured by Binance". Cryptocurrency exchange Binance is joining the race of...

El Salvador Passes Bill to Accept Bitcoin as Legal Tender

EI Salvador has become the first country in Central America to pass the bill to accept Bitcoin as legal tender. It has been disclosed...

Gaming Platform Xaya Teams Up with Popular Ethereum Scaling Solution Polygon

Blockchain Gaming platform Xaya has joined hands with popular Ethereum scaling solution Polygon. Xaya has partnered with Polygon to improve the scalability of its...

Why CynergisTek [CTEK] is Skyrocketing Today?

CynergisTek, Inc. skyrocketed 24.73% during the trading session of Wednesday. The positive performance of the firm indicated the positive sentiments of the investors...